Recent reporting revealed that Russia is rebuilding a major research center for biological weapons. China is deeply embedded in our critical biotech supply chains, giving the Chinese Communist Party the ability to wreak economic havoc on our people and markets.
These are just two examples of how emerging biotechnologies — from novel therapeutics to agricultural advances to defense applications — have the capability to reshape our economy and national security. If the United States does not lead in this area, our adversaries will, risking a future in which biotechnology undermines — rather than supports — our global priorities.
I serve as the chair of the National Security Commission on Emerging Biotechnology (NSCEB), a bipartisan group of lawmakers and policy experts working to assess the opportunities and threats presented by these technologies. Next year, we will publish a report for Congress that details actions needed to maintain and strengthen America’s global leadership position.
Read more about this effort here. |